CATECHOL-O-METHYLTRANSFERASE (COMT) IS DISPENSABLE FOR VASCULAR PROTECTION BY ESTRADIOL IN MICE

被引：0
|
作者：
Wilhelmson, A. S. K. [1 ]
Bourghardt, J. [1 ]
Fogelstrand, P. [1 ]
Gogos, J. A. [2 ,3 ]
Tivesten, A. [1 ]
机构：
[1] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Univ Hosp, Gothenburg, Sweden
[2] Columbia Univ, Dept Neurosci, New York, NY USA
[3] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2011年 / 12卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(11)70310-5
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
309
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [41] Inhibitors of catechol-O-methyltransferase sensitize mice to pain
    Kambur, O.
    Talka, R.
    Ansah, O. B.
    Kontinen, V. K.
    Pertovaara, A.
    Kalso, E.
    Mannisto, P. T.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (07) : 1553 - 1565
  • [42] EVIDENCE FOR LOCALIZATION OF CATECHOL-O-METHYLTRANSFERASE (COMT) IN DOG SAPHENOUS-VEIN
    GUIMARAE.S
    AZEVEDO, I
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 284 (04) : R24 - R24
  • [43] Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia
    Handoko, HY
    Nyholt, DR
    Hayward, NK
    Nertney, DA
    Hannah, DE
    Windus, LC
    McCormack, CM
    Smith, HJ
    Filippich, C
    James, MR
    Mowry, BJ
    MOLECULAR PSYCHIATRY, 2005, 10 (06) : 589 - 597
  • [44] Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia
    H Y Handoko
    D R Nyholt
    N K Hayward
    D A Nertney
    D E Hannah
    L C Windus
    C M McCormack
    H J Smith
    C Filippich
    M R James
    B J Mowry
    Molecular Psychiatry, 2005, 10 : 589 - 597
  • [45] Spasmolytic Effect of Flopropione Does Not Involve Catechol-O-methyltransferase (COMT) Inhibition
    Amagase, Yoko
    Hoshiyama, Mari
    Hasegawa, Shiho
    Kanbara, Miwa
    Mizukawa, Yumiko
    Urushidani, Tetsuro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (03) : 660 - 668
  • [46] What is the impact of catechol-O-methyltransferase (COMT) on Parkinson's disease treatment?
    Salamon, Andras
    Zadori, Denes
    Szpisjak, Laszlo
    Klivenyi, Peter
    Vecsei, Laszlo
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (10) : 1123 - 1128
  • [47] Catechol-O-methyltransferase (COMT) inhibitors in rat striatal glial cell cultures
    Reenilä, IT
    Tuomainen, P
    Soinila, S
    Mannistö, PT
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R60 - R60
  • [48] Expression of multiple catechol-o-methyltransferase (COMT) mRNA variants in human brain
    Tunbridge, Elizabeth M.
    Lane, Tracy A.
    Harrison, Paul J.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2007, 144B (06) : 834 - 839
  • [49] PARADOXICAL EFFECT OF TUMOR INHIBITOR, VERNOLEPIN, ON CATECHOL-O-METHYLTRANSFERASE (COMT) ACTIVITY
    LANTZ, CH
    LARNER, J
    FEDERATION PROCEEDINGS, 1974, 33 (03) : 556 - 556
  • [50] Effects of catechol-O-methyltransferase (COMT) inhibition on the pharmacokinetics of L-DOPA
    Nutt, JG
    PARKINSON'S DISEASE, 1996, 69 : 493 - 496
12345